Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 3
2022 6
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?
Ravlić S, Hećimović A, Kurtović T, Ivančić Jelečki J, Forčić D, Slović A, Kurolt IC, Mačak Šafranko Ž, Mušlin T, Rnjak D, Jakšić O, Sorić E, Džepina G, Đaković Rode O, Kujavec Šljivac K, Vuk T, Jukić I, Markotić A, Halassy B. Ravlić S, et al. Among authors: soric e. Front Immunol. 2022 Feb 22;13:816159. doi: 10.3389/fimmu.2022.816159. eCollection 2022. Front Immunol. 2022. PMID: 35273599 Free PMC article.
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis.
Lucijanic M, Galusic D, Soric E, Sedinic M, Cubela M, Huzjan Korunic R, Pejsa V, Kusec R. Lucijanic M, et al. Among authors: soric e. Ann Hematol. 2021 Apr;100(4):1105-1106. doi: 10.1007/s00277-020-04243-8. Epub 2020 Sep 1. Ann Hematol. 2021. PMID: 32870367 No abstract available.
Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients.
Lucijanic M, Jurin I, Sedinic Lacko M, Soric E, Sabljic A, Krecak I, Mitrovic J, Marelic D, Kremer Z, Hadzibegovic I, Lucijanic T, Kusec R. Lucijanic M, et al. Among authors: soric e. Thromb Res. 2022 Jun;214:37-39. doi: 10.1016/j.thromres.2022.04.009. Epub 2022 Apr 18. Thromb Res. 2022. PMID: 35461036 Free PMC article. No abstract available.
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis.
Lucijanic M, Krecak I, Soric E, Sabljic A, Galusic D, Holik H, Perisa V, Moric Peric M, Zekanovic I, Kusec R. Lucijanic M, et al. Among authors: soric e. Leuk Res. 2022 Aug;119:106905. doi: 10.1016/j.leukres.2022.106905. Epub 2022 Jun 21. Leuk Res. 2022. PMID: 35759912 No abstract available.
Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients.
Lucijanic M, Soric E, Sedinic Lacko M, Sabljic A, Krecak I, Bistrovic P, Jordan A, Manola S, Jaksic O, Lucijanic T, Derek L, Kusec R. Lucijanic M, et al. Among authors: soric e. J Med Virol. 2022 Aug;94(8):3509-3511. doi: 10.1002/jmv.27785. Epub 2022 Apr 21. J Med Virol. 2022. PMID: 35419812 Free PMC article. No abstract available.
Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time.
Lucijanic M, Veic P, Aric I, Tupek KM, Soric E, Sabljic A, Vlasac Glasnovic J, Stoos-Veic T, Krecak I, Kusec R. Lucijanic M, et al. Among authors: soric e. Ann Hematol. 2023 Jul;102(7):1955-1956. doi: 10.1007/s00277-023-05305-3. Epub 2023 Jun 3. Ann Hematol. 2023. PMID: 37269389 No abstract available.
16 results